Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3)



Similar documents
DSM-5 and its use by chemical dependency professionals

What is Addiction? DSM-IV-TR Substance Abuse Criteria

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.

Experiences of Assessing Misuse, Abuse and Opioid Use Disorders in Patients with Pain on Opioid Therapy

Background & Significance

DSM 5 SUBSTANCE USE DISORDERS. Ronald W. Kanwischer LCPC, CADC Professor Emeritus Department of Psychiatry SIU School of Medicine

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

Substance Related Disorders. Substance Abuse. Substance Use Disorders 4/3/2012. Substance Abuse. Substance Dependency

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine.

Reference document. Alcohol addiction

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Prescription Drug Abuse

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

Amphetamines Addiction

The Chemical Coper Steven D. Passik, PhD

Opioid Treatment Agreement

Measuring Addiction with DSM Criteria. May 20, 2014 Deborah Hasin, Ph.D. Columbia University

Substance Use Disorder Screening and Testing

Chapter 7. Screening and Assessment

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

Iowa Governor s Office of Drug Control Policy

ADDICTIONS. BEHAVIOURAL Internet Shopping Work Sex Gambling Food. SUBSTANCE - RELATED Alcohol Drugs Medicine Tobacco

Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain

Pain, Addiction & Methadone

2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California

How To Diagnose And Treat An Alcoholic Problem

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse?

Identifying and Treating Dual-Diagnosed Substance Use and Mental Health Disorders. Presented by: Carrie Terrill, LCDC

Depression Assessment & Treatment

Assessment and Diagnosis of DSM-5 Substance-Related Disorders

Guidelines for Use of Controlled Substances for the Treatment of Pain

Provide school-based and community-based shared language. Strength relationships between mental health providers, school staff and community at large

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Benzodiazepine Detoxification and Reduction of Long term Use

Pragmatic Evidence Based Review Substance Abuse in moderate to severe TBI

Drug Abuse and Addiction

Methamphetamine. Like heroin, meth is a drug that is illegal in some areas of the world. Meth is a highly addictive drug.

CHPN Review Course Pain Management Part 1 Hospice and Palliative Nurses Association

Metropolitan Detention Center (MDC) DWI Addiction Treatment Programs (ATP) Outcome Study for DWI Offenders

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model

Prescription Medication Abuse: Skills for Prevention and Intervention

A Depression Education Toolkit

Indiana University Health

Alcohol and Dependence

Medical Cannabis and Addictions. October 2015 Charlie Reznikoff

PRESCRIPTION DRUG ABUSE prevention

Dr. Tina Parkman LPC, CAADC 7 points to Total Recovery!

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest

San Mateo County Alcohol and Other Drug Services New Medication Policy

Traumatic Stress. and Substance Use Problems

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

Treating Pain: New Guidelines for Using Controlled Substances. Jason F. Arnold, JD, MPH Associate Director, Institute of Human Values in Health Care

DRAFT Metropolitan Detention Center (MDC) DWI Addiction Treatment Programs (ATP) Outcome Study Final Report UPDATED

Borderline personality disorder

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015

Cocaine. Like heroin, cocaine is a drug that is illegal in some areas of the world. Cocaine is a commonly abused drug.

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

Aberrant Drug-taking Behaviors: What Do We Know?

Depression & Multiple Sclerosis

ADVISORY OPINION THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF CHRONIC PAIN

Alcohol & Chemical Dependence. Chisoo Choi, M.D. Internal Medicine Consultant Brookhaven Hospital Tulsa, Oklahoma

With Depression Without Depression 8.0% 1.8% Alcohol Disorder Drug Disorder Alcohol or Drug Disorder

"BARRIERS TO HIV PREVENTION AND CARE DUE TO CONSUMER SUBSTANCE ABUSE AND CHEMICAL DEPENDENCE PART II.

Drug and Alcohol Assessment

Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft***

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Michigan Department of Licensing and Regulatory Affairs Pain and Symptom Management Speakers Bureau

Treatment Approaches for Drug Addiction

Getting the best result from Opioid medicine. in the management of chronic pain

mental health-substance use

Depression & Multiple Sclerosis. Managing Specific Issues

Considerations when Using Controlled Substances to Treat Chronic Pain

MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain

OTC Abuse. Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University

OVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use

ENTITLEMENT ELIGIBILITY GUIDELINE ALCOHOL USE DISORDER

DSM 5 Opioid Related Disorders. Dr. Phil O Dwyer Oakland University Brookfield Clinics

Frequently asked questions

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM

Memantine (Ebixa) Drug treatment for Alzheimer s disease

LEVEL III.5 SA: SHORT TERM RESIDENTIAL - Adult (DUAL DIAGNOSIS CAPABLE)

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)

Transcription:

Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3) James Elander University of Derby j.elander@derby.ac.uk http://psychology.derby.ac.uk/staff/james_elander.html SCOOTER Project http://www.sicklecellanaemia.org

What this presentation is about Assessment of painkiller addiction/dependence generally The concept of pseudoaddiction Rates of painkiller addiction/dependence in other painful conditions A more accurate method to assess addiction and pseudoaddiction among people with painful conditions Findings from a study of SCD

Assessment of painkiller addiction Prescribed rather than illicit drugs Benefits rather than harm due to drug use Some symptoms of dependence to be expected

Diagnosing substance dependence in the absence of pain Three or more of these symptoms: 1. Tolerance (needing larger doses) 2. Withdrawal symptoms 3. Taking more than intended 4. Persistent desire or unsuccessful attempts to give up or cut down 5. Excessive time spent obtaining, using or recovering from drug use 6. Social, occupation or recreation activities given up or reduced because of drug use 7. Continued use despite knowledge of problems caused by drug use (DSM-IV, American Psychiatric Association, 2000)

Diagnosing substance abuse in the absence of pain One or more of these symptoms: 1. Recurrent substance use resulting in failures to fulfil major role obligations at work, school or home. 2. Recurrent substance use in physically hazardous situations (e.g., driving or operating a machine when impaired by substance use). 3. Recurrent substance-related legal problems. 4. Continued substance use despite persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance. (DSM-IV, American Psychiatric Association, 2000)

Consensus definitions of opiate use in treatment of pain Physical dependence state of adaptation... produced by abrupt cessation, rapid dose reduction... Tolerance exposure to a drug induces... diminution of the drug s effects over time Addiction Primary, chronic, neurobiologic disease, characterised by one or more of: Impaired control over drug use Compulsive use Continued use despite harm Craving (American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine see Savage et al., 2003)

Consensus statement on problem opiate use in treatment of pain...no single event is diagnostic of addictive disorder. Rather, the diagnosis is made in response to a pattern of behavior that usually becomes obvious over time good clinical judgement must be used in determining whether the pattern of behaviour signals addiction definitions do not constitute formal diagnostic criteria... may serve as a basis for future development of more specific, universally accepted diagnostic guidelines (Savage et al., 2003)

Factors associated with painkiller addiction in chronic pain Prescription forgery Preference for injecting Illicit drug use But not: Aggressive complaining/arguments about pain Unsanctioned dose increases Using multiple prescribers ( drug-seeking behaviours ) (Kirsh et al., 2002)

Pseudoaddiction Patients reports of pain are not accepted or believed They resort to exaggerated or manipulative pain behaviours to obtain pain relief Those behaviours are perceived by staff as signs of drug addiction (Weissman & Haddox, 1989)

What about in sickle cell disease? Can we assess genuine painkiller dependence versus pseudo-addiction? Which of those is more common, and what are the rates of each?

The study Semi-structured interviews with 51 adult patients with SCD 17 (33%) male, 34 (67%) female Age 17-57 years (mean 34, SD 10) 38 (75%) Hb SS, 13 (26%) Hb SC or Hb SBeta Thal (Elander et al., 2003; Lusher et al., 2006)

Interviews about symptoms of substance abuse/dependence 1. Tolerance 2. Withdrawal 3. Greater use than intended 4. Attempt to give up or cut down 5. Excessive time spent 6. Social impairment 7. Use despite known problems 8. Failing role obligations 9. Use in physically hazardous situations 10. Legal problems 11. Use despite social or interpersonal problems 12. Craving

Classification of symptoms reported Pain-related symptoms Resemble DSM-IV symptoms, but are observed only in the presence of pain or attempts to control pain. Would make patients vulnerable to misperceptions of addiction, and increase the risk of pseudoaddiction Non-pain-related symptoms Also resemble DSM-IV symptoms, but are observed in the absence of pain, or where drugs are used for effects other than analgesia (eg to alter mood, obtain euphoria). Provide a measure of true addiction, discounting drug needs for pain

Examples of symptoms classified as pain-related and non-pain-related Pain-related symptoms I found I needed more and more medication [to manage pain at home and avoid going into hospital] (Tolerance) sometimes I am tempted to take it more frequently than prescribed, say when I am still in pain after two hours (Greater use than intended) I have done that before [taking more painkillers], thinking the more I take, the faster the pain would go (Greater use than intended) it makes my skin itch and makes me feel drowsy but nothing else works. I try not to take it again but the pain always comes back (Attempt to cut down) if the pain is really severe and I take a high dose. The tablets make me sleepy and I have to go to bed, so I am not able to go out (Social impairment) Non-pain-related symptoms I couldn t sleep without them [pain killers]. I was restless at night, walking up and down and feeling depressed (Withdrawal symptoms) I have taken an excess amount, because of my psychological state; I was stressed and thinking of killing myself (Greater use than intended) I took two, three, or even four, I was, like, high (Greater use than intended) I knew I was becoming dependent and I weaned myself off (Attempt to cut down) I was going through problems depression. I was staying indoors and not working and being awake all night (Social impairment)

Most frequent symptoms 1. Attempt to give up or cut down (59% PR, 8% NPR) 2. Tolerance (43% PR, 4% NPR) 3. Social impairment (41% PR, 2% NPR) 4. Greater use than intended (35% PR, 10% NPR) 5. Failing role obligations (31% PR, 2% NPR) 6. Withdrawal (24% PR, 8% NPR) (PR = pain-related, NPR = non-pain-related) (Elander et al., 2003)

Least frequent symptoms 1. Legal problems (2% PR, 2% NPR) 2. Craving (12% PR, 6% NPR) 3. Use despite known problems (16% PR, 2% NPR) 4. Excessive time spent (18% PR, 0% NPR) 5. Use in physically hazardous situations (18% PR, 0% NPR) 6. Use despite social/interpersonal problems (20% PR, 0% NPR) (PR = pain-related, NPR = non-pain-related) (Elander et al., 2003)

What factors associated with what symptoms? (Lusher et al., 2006) Pain-related symptoms (risk of pseudoaddiction) Non-pain-related symptoms (genuine addiction) Physiological symptoms Behavioural symptoms Illicit drug use (β.31, p.03) OTC 1 drug use (β.34, p.02) Disputes (β.34, p.01) Behavioural coping strategies (β.25, p.06) Injecting painkillers (β.43, p.004) Physiological symptoms (β.31, p.03) Illicit drug use (β.31, p.04) β = standardised regression coefficient p = probability 1. OTC = over-the-counter

How many people reported how many symptoms? 80 Percent of participants 70 60 50 40 30 20 10 0 0 1 2 3 4 5 6 7 8 9 Number of symptoms Non-pain-related Pain-related

Conclusions so far Rates of genuine painkiller addiction quite low in SCD, and comparable to other painful conditions But many attempts to relieve pain can be misperceived as drug-seeking Patients with use of painkillers that could be misperceived as addiction are risk of pseudoaddiction Could these factors help to explain SCD patients problematic experiences of hospital pain management?

Reminder about concern-raising behaviours in hospital Staff-patient disputes Accusations/suspicions of painkiller abuse Using non-prescribed painkillers Tampering with analgesic delivery systems Self-discharge from hospital Indicators of: Breakdowns of patient-provider trust Poor hospital pain management

Two hypotheses 1. CRBs caused by pseudoaddiction and undertreatment of pain 2. CRBs caused by painkiller dependence and patients drug-seeking

Which symptoms related to problematic hospital outcomes? (Elander et al., 2004) Pain-related symptoms (pseudoaddiction) Odds ratio 2 = 2.3 (95% CI 1.2 to 4.4) CRBs 1 Non-pain-related symptoms (genuine painkiller addiction) Odds ratio = 1.0 (95% CI 0.4 to 2.8) 1. Disputes, tampering with pumps, passing analgesics, self-discharge, accused by staff of painkiller abuse

More conclusions The addiction/pseudoaddiction distinction is important, despite the superficial similarity Disputes and other problematic outcomes in hospital: More likely the result of patient behaviours perceived as addiction Unlikely to result from genuine painkiller dependence More research needed on how patient behaviours are perceived by hospital staff

Collaborators and Thanks Collaborators David Bevan, St George s Hospital Bernice Burton, Plaistow Hospital Jo Lusher, London Metropolitan University Paul Telfer, Royal London Hospital Thanks also to REMEDI and London Metropolitan University (funding) Nadine Hay (SC unit, Balham Health Centre) Bernice Thomas (Wandsworth SC support Group)

References American Psychiatric Association (2000). DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorder (4 th Ed.). Washington DC: American Psychiatric Association. Elander, J., Lusher, J., Bevan, D., Telfer, P. and Burton, B. (2004). Understanding the causes of problematic pain management in sickle cell disease: Evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. Journal of Pain and Symptom Management, 27, 156-169. Elander, J., Lusher, J., Bevan, D. and Telfer, P. (2003). Pain management and symptoms of substance dependence among patients with sickle cell disease. Social Science and Medicine, 57, 1683-1696. Kirsh, K.L., Whitcomb, L.A., Donaghy, K. & Passik, S.D. (2002). Abuse and addiction issues in medically ill patients with pain: Attempts at clarification of terms and empirical study. Clinical Journal of Pain, 18, S52-S60. Lusher, J., Elander, J., Bevan, D., Telfer, P. and Burton, B. (2006). Analgesic addiction and pseudoaddiction in painful chronic illness. Clinical Journal of Pain, 22, 316-324. Savage SR, Joranson DE, Covington EC, et al. (2003). Definitions related to the medical use of opioids: evolution towards universal agreement. Journal of Pain and Symptom Management, 26, 655 667. Weissman, D.E. and Haddox, J.D. (1989). Opioid pseudoaddiction: an iatrogenic syndrome. Pain, 36, 363-366.